Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 3/20 | 0.53 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.53 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.50 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.50 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.42 |
| ▸ | CPT2 | P23786 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.42 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.40 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18775013 | 1.00 | GRIK1 (0.53) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL2913235 | 1.00 | GRIK1 (0.53) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL18775015 | 0.98 | GRIK1 (0.51) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL18775024 | 0.93 | SLC1A2 (0.50) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL18775019 | 0.93 | SLC1A2 (0.50) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL18775012 | 0.93 | SLC1A2 (0.50) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL25006715 | 0.86 | GRIK1 (0.53) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL18762598 | 0.85 | SLC1A2 (0.44) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL18775003 | 0.85 | SLC1A2 (0.44) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL18775000 | 0.85 | SLC1A2 (0.44) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210337850-A1 | SAVOURY AND MOUTHFULNESS TASTE ENHANCERS | LUCTA, S.A. (ES) | 2021-11-04 | — | — | US | disclosed |
| US-11124525-B2 | Heteroaryl compounds useful as MK2 inhibitors | CELGENE CAR LLC (BM) | 2021-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210337850-A1 | SAVOURY AND MOUTHFULNESS TASTE ENHANCERS | KCNJ6, TAS1R1, TAS2R5 | GRIK1 98/4885GRIK2 215/4885SLC1A2 4049/4885 |
| US-11124525-B2 | Heteroaryl compounds useful as MK2 inhibitors | MKNK2, MKRN3, MKNK1 | GRIK1 847/4885GRIK2 170/4885SLC1A2 3669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.